Droplet digital PCR-based testing for donor-derived cell-free DNA in transplanted patients as noninvasive marker of allograft health: Methodological aspects
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0282332 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Frederik Banch Clausen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Cell-Free Nucleic Acids, Organ Transplantation. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Toyota Foundation, Bloddonorerne i Danmark, Læge Sophus Carl Emil Friis og hustru Olga Doris Friis’ Legat.
Abstract (Originalsprache)
In solid organ transplantation, donor-derived cell-free DNA (dd-cfDNA) is a promising universal noninvasive biomarker for allograft health, where high levels of dd-cfDNA indicate organ damage. Using Droplet Digital PCR (ddPCR), we aimed to develop an assay setup for monitoring organ health. We aimed to identify the least distinguishable percentage-point increase in the fraction of minute amounts of cfDNA in a large cfDNA background by using assays targeting single nucleotide polymorphisms (SNPs). We mimicked a clinical sample from a recipient in a number of spike-in experiments, where cfDNA from healthy volunteers were mixed. A total of 40 assays were tested and approved by qPCR and ddPCR. Limit of detection (LOD) was demonstrated to be approximately 3 copies per reaction, observed at a fraction of 0.002%, and which would equal 6 copies per mL plasma. Limit of quantification (LOQ) was 35 copies per reaction, estimated to 0.038%. The lowest detectable increase in percentage point of dd-cfDNA was approximately 0.04%. Our results demonstrated that ddPCR has great sensitivity, high precision, and exceptional ability to quantify low levels of cfDNA. The ability to distinguish small differences in mimicking dd-cfDNA was far beyond the desired capability. While these methodological data are promising, further prospective studies are needed to determine the clinical utility of the proposed method.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark.
- Department of Technology, Faculty of Health, University College Copenhagen, Copenhagen, Denmark.
ORCID-Profile: Frederik Banch Clausen
Förderung
- Toyota Foundation
- Bloddonorerne i Danmark
- Læge Sophus Carl Emil Friis og hustru Olga Doris Friis’ Legat
Zitieren
APA
Clausen, F. B., Jørgensen, K. M. C. L., Wardil, L. W., Nielsen, L. K., & Krog, G. R. (2023). Droplet digital PCR-based testing for donor-derived cell-free DNA in transplanted patients as noninvasive marker of allograft health: Methodological aspects. PLOS ONE. https://doi.org/10.1371/journal.pone.0282332
Vancouver
Clausen FB, Jørgensen KMCL, Wardil LW, Nielsen LK, Krog GR. Droplet digital PCR-based testing for donor-derived cell-free DNA in transplanted patients as noninvasive marker of allograft health: Methodological aspects. PLOS ONE. 2023. doi:10.1371/journal.pone.0282332
BibTeX
@article{Clausen2023,
author = {Clausen, Frederik Banch and Jørgensen, Kristine Mathilde Clara Lund and Wardil, Lasse Witt and Nielsen, Leif Kofoed and Krog, Grethe Risum},
title = {Droplet digital PCR-based testing for donor-derived cell-free DNA in transplanted patients as noninvasive marker of allograft health: Methodological aspects},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0282332}
}
EUVIMED